Biodesix is a data-driven diagnostic solutions company utilizing technologies with its proprietary artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. In addition to diagnostic tests, Co. provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. Co.'s diagnostic blood-based tests across the lung cancer continuum of care include: Nodify XL2® and Nodify CDT® tests, which assess the risk of lung cancer to help identify the appropriate treatment pathway. We show 15 historical shares outstanding datapoints in our BDSX shares outstanding history coverage, used to compute BDSX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BDSX market cap history over the course of time is important for investors
interested in comparing BDSX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BDSX versus a peer is one thing; comparing
BDSX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BDSX can fluctuate over the course of history.
With this page we aim to empower investors researching BDSX by allowing them to research the BDSX market cap history. |
Free BDSX Email Alerts:
Video: The Importance of Market Cap
